IP Library Granted Patent US 7,964,729
Granted Patent B2
US 7,964,729 · App. 11/511,050 · Granted Jun 21, 2011

Sox-based kinase sensor

Assignee: Massachusetts Institute of Technology
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,964,729
App. No.
11/511,050
Granted
Jun 21, 2011
Kind
B2
Abstract

Peptidyl sensors comprise a metal-binding peptide and one or two kinase recognition sequences with a hydroxyamino acid that can be phosphorylated in the presence of a kinase.

Claims (86)

1. A compound of structure (I):

wherein R 1 is hydroxy, amino, or thiol;

R 2 and R 3 are each independently hydrogen, an electron-withdrawing group, or —SO 2 X;

each R 4 is independently hydrogen, an electron-withdrawing group or —SO 2 X, wherein R 4 can substitute any open valence of any ring within structure (I);

X is —OR′ or —NR′R″;

Y is halogen, —SH, —NR′R′″, —CHO, or —CO 2 H;

R′ and R″ are each independently hydrogen or C 1-6 alkyl;

R′″ is hydrogen, unsubstituted C 1-6 alkyl, tBoc or Fmoc;

n is 0, 1, 2 or 3; and

m is 1, 2, or 3, and

wherein at least one of R 2 , R 3 or R 4 is —SO 2 X and at least another one of R 2 , R 3 or R 4 is an electron-withdrawing group.

2. The compound of claim 1 , which has the structure:

wherein R 1 is hydroxy, amino, or thiol;

R 2 and R 3 are each independently hydrogen, an electron-withdrawing group, or —SO 2 X;

each R 4 is independently hydrogen, an electron-withdrawing group or —SO 2 X, wherein R 4 can substitute any open valence of any ring within the structure;

X is —OR′ or —NR′R″;

Y is halogen, —SH, —NR′R′″, —CHO, or —CO 2 H;

R′ and R″ are each independently hydrogen or C 1-6 alkyl;

R′″ is hydrogen, unsubstituted C 1-6 alkyl, tBoc or Fmoc;

n is 0, 1, 2 or 3; and

m is 1 or 2, and

wherein at least one of R 2 , R 3 or R 4 is an electron-withdrawing group.

3. The compound of claim 1 , which has the structure:

wherein R 2 and R 3 are each independently hydrogen, an electron-withdrawing group, or —SO 2 X;

each R 4 is independently hydrogen, an electron-withdrawing group or —SO 2 X, wherein R 4 can substitute any open valence of any ring within the structure;

X is —OR′ or —NR′R″;

Y is halogen, —SH, —NR′R′″, —CHO, or —CO 2 H;

R′ and R″ are each independently hydrogen or C 1-6 alkyl;

R′″ is hydrogen, unsubstituted C 1-6 alkyl, tBoc or Fmoc;

n is 0, 1, 2 or 3; and

m is 1, 2 or 3, and

wherein at least one of R 2 , R 3 or R 4 is —SO 2 X and at least another one of R 2 , R 3 or R 4 is an electron-withdrawing group.

4. The compound of claim 1 , which has the structure:

wherein R 2 and R 3 are each independently hydrogen, an electron-withdrawing group, or —SO 2 X;

each R 4 is independently hydrogen, an electron-withdrawing group or —SO 2 X, wherein R 4 can substitute any open valence of any ring within the structure;

X is —OR′ or —NR′R″;

Y is halogen, —SH, —NR′R′″, —CHO, or —CO 2 H;

R′ and R″ are each independently hydrogen or C 1-6 alkyl;

R′″ is hydrogen, unsubstituted C 1-6 alkyl, tBoc or Fmoc;

n is 0, 1, 2 or 3; and

m is 1 or 2, and

wherein at least one of R 2 , R 3 or R 4 is an electron-withdrawing group.

5. A peptide comprising an amino acid residue, the side chain of the amino acid residue modified with a compound of structure (I):

wherein R 1 is hydroxy, amino, or thiol;

R 2 and R 3 are each independently hydrogen, an electron-withdrawing group, or —SO 2 X;

each R 4 is independently hydrogen, an electron-withdrawing group or —SO 2 X, wherein R 4 can substitute any open valence of any ring within structure (I);

X is —OR′ or —NR′R″;

Y is halogen, —SH, —NR′R′″, —CHO, or —CO 2 H;

R′ and R″ are each independently hydrogen or C 1-6 alkyl;

R′″ is hydrogen, C 1-6 alkyl, tBoc or Fmoc;

n is 0, 1, 2 or 3; and

m is 1, 2 or 3, 4, and

wherein at least one of R 2 , R 3 or R 4 is —SO 2 X and at least another one of R 2 , R 3 or R 4 is an electron-withdrawing group.

6. The peptide of claim 5 , wherein the peptide further comprises a kinase recognition sequence.

7. The peptide of claim 5 , wherein the peptide further comprises two kinase recognition sequences.

8. The compound of claim 1 , which has the structure:

wherein R 1 is hydroxy, amino, or thiol;

R 2 and R 3 are each hydrogen;

each R 4 is independently hydrogen, an electron-withdrawing group or —SO 2 X, wherein R 4 can substitute any open valence of any ring within the structure;

X is —OR′ or —NR′R″;

Y is halogen, —SH, —NR′R′″, —CHO, or —CO 2 H;

R′ and R″ are each independently hydrogen or C 1-6 alkyl;

R′″ is hydrogen, unsubstituted C 1-6 alkyl, tBoc or Fmoc;

n is 0, 1, 2 or 3; and

m is 1 or 2, and

wherein at least one R 4 is an electron-withdrawing group.

9. The compound of claim 1 , which has the structure:

wherein R 2 and R 3 are each hydrogen;

each R 4 is independently hydrogen, an electron-withdrawing group or —SO 2 X, wherein R 4 can substitute any open valence of any ring within the structure;

X is —OR′ or —NR′R″;

Y is halogen, —SH, —NR′R′″, —CHO, or —CO 2 H;

R′ and R″ are each independently hydrogen or C 1-6 alkyl;

R′″ is hydrogen, unsubstituted C 1-6 alkyl, tBoc or Fmoc;

n is 0, 1, 2 or 3; and

m is 1, 2 or 3, and

wherein at least one R 4 is —SO 2 X and at least another one of R 4 is an electron-withdrawing group.

10. The compound of claim 1 , which has the structure:

wherein R 2 and R 3 are each hydrogen;

each R 4 is independently hydrogen, an electron-withdrawing group or —SO 2 X, wherein R 4 can substitute any open valence of any ring within the structure;

X is —OR′ or —NR′R″;

Y is halogen, —SH, —NR′R′″, —CHO, or —CO 2 H;

R′ and R″ are each independently hydrogen or C 1-6 alkyl;

R′″ is hydrogen, unsubstituted C 1-6 alkyl, tBoc or Fmoc;

n is 0, 1, 2 or 3; and

m is 1 or 2, and

wherein at least one R 4 is an electron-withdrawing group.

Assignments (3)
CONFIRMATORY LICENSE Recorded Dec 9, 2011
From: MASSACHUSETTS INSTITUTE OF TECHNOLOGY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 027356/0804 →
CONFIRMATORY LICENSE Recorded Mar 10, 2011
From: MASSACHUSETTS INSTITUTE OF TECHNOLOGY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 025920/0991 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 28, 2006
From: IMPERIALI, BABARA; LUKOVIC, ELVEDIN; CARRICO-MONIZ, DORA
To: MASSACHUSETTS INSTITUTE OF TECHNOLOGY
Reel/Frame 018245/0326 →
Continuity (1)
Related Publication 20080050761A1 · Feb 28, 2008